Tech Company Financing Transactions
Enterprise Therapeutics Funding Round
Panakes Partners, Epidarex Capital and Forbion Capital Partners participated in a $32.8 million Series B funding round for Enterprise Therapeutics. This venture round was announced on 1/30/2024.
Transaction Overview
Company Name
Announced On
1/30/2024
Transaction Type
Venture Equity
Amount
$32,780,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the Phase 2a clinical trial of its lead program, ETD001, to deliver clinical proof of concept to treat cystic fibrosis and expand clinical activities into Italy via addition of clinical investigator sites and progression of its other preclinical programs targeting mucus congestion.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Sussex Innovation Centre University of Sussex Science Park S
Brighton, BN1 9SB
UK
Brighton, BN1 9SB
UK
Phone
Email Address
Overview
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. The company is backed by top tier venture capital investors and is based in the UK with offices at the University of Sussex Innovation Centre and in Blackfriars, London.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Ford
Chief Financial Officer
Phil Boyd
Chief Medical Officer
Niyati Prasad
Chief Scientific Officer
Martin Gosling
VP - Bus. Development
Paul Russell
Browse more venture capital transactions:
Prev: 1/30/2024: Cour Pharmaceuticals venture capital transaction
Next: 1/30/2024: Cultivo venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions on this site are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs